No Cover Image

Journal article 41 views

Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial

Linong Ji Orcid Logo, Rikke M. Agesen Orcid Logo, Steve Bain Orcid Logo, Fangming Fu Orcid Logo, Sanaz Gabery Orcid Logo, Jianlin Geng Orcid Logo, Yiming Li Orcid Logo, Yibing Lu, Bifen Luo Orcid Logo, Wuyan Pang, Yi Tao Orcid Logo, (for the PIONEER 12 investigators)

Diabetologia

Swansea University Author: Steve Bain Orcid Logo

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1007/s00125-024-06133-4

Published in: Diabetologia
ISSN: 0012-186X 1432-0428
Published: Springer Science and Business Media LLC
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa67081
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2024-07-12T12:36:02Z
last_indexed 2024-07-12T12:36:02Z
id cronfa67081
recordtype SURis
fullrecord <?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>67081</id><entry>2024-07-12</entry><title>Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-07-12</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetologia</journal><volume/><journalNumber/><paginationStart/><paginationEnd/><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0012-186X</issnPrint><issnElectronic>1432-0428</issnElectronic><keywords/><publishedDay>0</publishedDay><publishedMonth>0</publishedMonth><publishedYear>0</publishedYear><publishedDate>0001-01-01</publishedDate><doi>10.1007/s00125-024-06133-4</doi><url>http://dx.doi.org/10.1007/s00125-024-06133-4</url><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2024-07-12T13:36:03.1159639</lastEdited><Created>2024-07-12T13:34:44.3854710</Created><path><level id="1">Swansea University Medical School</level><level id="2">Swansea University Medical School</level></path><authors><author><firstname>Linong</firstname><surname>Ji</surname><orcid>0000-0002-3262-2168</orcid><order>1</order></author><author><firstname>Rikke M.</firstname><surname>Agesen</surname><orcid>0000-0002-7649-7928</orcid><order>2</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>3</order></author><author><firstname>Fangming</firstname><surname>Fu</surname><orcid>0000-0002-0874-7526</orcid><order>4</order></author><author><firstname>Sanaz</firstname><surname>Gabery</surname><orcid>0000-0002-2243-7540</orcid><order>5</order></author><author><firstname>Jianlin</firstname><surname>Geng</surname><orcid>0009-0001-6844-9221</orcid><order>6</order></author><author><firstname>Yiming</firstname><surname>Li</surname><orcid>0000-0002-1828-8765</orcid><order>7</order></author><author><firstname>Yibing</firstname><surname>Lu</surname><order>8</order></author><author><firstname>Bifen</firstname><surname>Luo</surname><orcid>0000-0001-7166-278x</orcid><order>9</order></author><author><firstname>Wuyan</firstname><surname>Pang</surname><order>10</order></author><author><firstname>Yi</firstname><surname>Tao</surname><orcid>0009-0003-6453-5354</orcid><order>11</order></author><author><firstname>(for the PIONEER 12</firstname><surname>investigators)</surname><order>12</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling v2 67081 2024-07-12 Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2024-07-12 MEDS Journal Article Diabetologia Springer Science and Business Media LLC 0012-186X 1432-0428 0 0 0 0001-01-01 10.1007/s00125-024-06133-4 http://dx.doi.org/10.1007/s00125-024-06133-4 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2024-07-12T13:36:03.1159639 2024-07-12T13:34:44.3854710 Swansea University Medical School Swansea University Medical School Linong Ji 0000-0002-3262-2168 1 Rikke M. Agesen 0000-0002-7649-7928 2 Steve Bain 0000-0001-8519-4964 3 Fangming Fu 0000-0002-0874-7526 4 Sanaz Gabery 0000-0002-2243-7540 5 Jianlin Geng 0009-0001-6844-9221 6 Yiming Li 0000-0002-1828-8765 7 Yibing Lu 8 Bifen Luo 0000-0001-7166-278x 9 Wuyan Pang 10 Yi Tao 0009-0003-6453-5354 11 (for the PIONEER 12 investigators) 12
title Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
spellingShingle Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
Steve Bain
title_short Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
title_full Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
title_fullStr Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
title_full_unstemmed Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
title_sort Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Linong Ji
Rikke M. Agesen
Steve Bain
Fangming Fu
Sanaz Gabery
Jianlin Geng
Yiming Li
Yibing Lu
Bifen Luo
Wuyan Pang
Yi Tao
(for the PIONEER 12 investigators)
format Journal article
container_title Diabetologia
institution Swansea University
issn 0012-186X
1432-0428
doi_str_mv 10.1007/s00125-024-06133-4
publisher Springer Science and Business Media LLC
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Swansea University Medical School{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Swansea University Medical School
url http://dx.doi.org/10.1007/s00125-024-06133-4
document_store_str 0
active_str 0
published_date 0001-01-01T13:36:02Z
_version_ 1804376748666650624
score 11.016213

Similar Items